Literature DB >> 18835388

Re-weighting the model for end-stage liver disease score components.

Pratima Sharma1, Douglas E Schaubel, Camelia S Sima, Robert M Merion, Anna S F Lok.   

Abstract

BACKGROUND & AIMS: Liver transplant candidates with mild hepatic synthetic dysfunction and marked renal insufficiency may have higher Model for End-Stage Liver Disease (MELD) scores than candidates with severe liver disease and normal renal function. We re-estimated MELD coefficients and evaluated the effect of updated MELD on the liver transplant waiting list ranking.
METHODS: Scientific Registry of Transplant Recipients data was analyzed for 38,899 adults wait-listed between September, 2001 and December, 2006. A time-dependent Cox regression waiting list mortality model estimated updated MELD component coefficients. Rank correlation between existing and updated MELD scores was computed.
RESULTS: Existing MELD component coefficient (log(e) creatinine, 0.957 vs 1.266 [95% confidence interval (CI), 1.21-1.32]; log(e) bilirubin, 0.378 vs 0.939 [95% CI, 0.91-0.97]; log(e) international normalized ratio, 1.120 vs 1.658 [95% CI, 1.58-1.74]) was significantly different than updated counterpart. Index of concordance was higher for updated MELD than existing MELD for predicting overall (0.68 vs. 0.64) and 90-day waiting list mortality (0.77 vs. 0.75). Rank correlation between existing and updated MELD scores was 0.95 for all candidates and 0.72 for candidates with existing MELD >or=20. Among candidates with equal existing MELD, those with lower creatinine and higher bilirubin had significantly higher waiting list mortality.
CONCLUSIONS: Existing MELD coefficient components are significantly different than those calculated from national waiting list data. Updated MELD assigns lower weight to creatinine and international normalized ratio and higher weight to bilirubin. Updated MELD better predicts waiting list mortality. Using updated MELD for liver allocation would alter waiting list candidate ranking.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835388     DOI: 10.1053/j.gastro.2008.08.004

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  48 in total

1.  Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.

Authors:  David Goldberg; Benjamin French; Arwin Thomasson; K Rajender Reddy; Scott D Halpern
Journal:  Liver Transpl       Date:  2011-11       Impact factor: 5.799

Review 2.  Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Authors:  Pratima Sharma; Khurram Bari
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

3.  Patient-specific prediction of ESRD after liver transplantation.

Authors:  Pratima Sharma; Nathan P Goodrich; Douglas E Schaubel; Mary K Guidinger; Robert M Merion
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

Review 4.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

5.  Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.

Authors:  Maximilian Jara; Tomasz Dziodzio; Maciej Malinowski; Katja Lüttgert; Radoslav Nikolov; Paul Viktor Ritschl; Robert Öllinger; Johann Pratschke; Martin Stockmann
Journal:  Dig Dis Sci       Date:  2018-11-07       Impact factor: 3.199

6.  Impact of MELD-based allocation on end-stage renal disease after liver transplantation.

Authors:  P Sharma; D E Schaubel; M K Guidinger; N P Goodrich; A O Ojo; R M Merion
Journal:  Am J Transplant       Date:  2011-08-22       Impact factor: 8.086

7.  Presumed Consent: A Potential Tool for Countries Experiencing an Organ Donation Crisis.

Authors:  Sammy Saab; Satvir S Saggi; Mizna Akbar; Gina Choi
Journal:  Dig Dis Sci       Date:  2018-12-05       Impact factor: 3.199

8.  Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction.

Authors:  Pratima Sharma; Xu Shu; Douglas E Schaubel; Randall S Sung; John C Magee
Journal:  Liver Transpl       Date:  2016-01       Impact factor: 5.799

9.  Sarcopenia and mortality after liver transplantation.

Authors:  Michael J Englesbe; Shaun P Patel; Kevin He; Raymond J Lynch; Douglas E Schaubel; Calista Harbaugh; Sven A Holcombe; Stewart C Wang; Dorry L Segev; Christopher J Sonnenday
Journal:  J Am Coll Surg       Date:  2010-06-26       Impact factor: 6.113

10.  Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.

Authors:  Yan-Hua Lai; Wei-Dong Duan; Qiang Yu; Sheng Ye; Nian-Jun Xiao; Dong-Xin Zhang; Zhi-Qiang Huang; Zhan-Yu Yang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.